Debt-to-equity of Olema Pharmaceuticals, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Olema Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Olema Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 10%, a 13% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Olema Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 10% -1.5% -13% 30 Sep 2025
Q2 2025 10% +0.57% +5.9% 30 Jun 2025
Q1 2025 10% +1.3% +15% 31 Mar 2025
Q4 2024 12% +3% +33% 31 Dec 2024
Q3 2024 12% +2.9% +33% 30 Sep 2024
Q2 2024 9.6% +0.41% +4.5% 30 Jun 2024
Q1 2024 9.1% +0.91% +11% 31 Mar 2024
Q4 2023 9% +2.5% +39% 31 Dec 2023
Q3 2023 9% +3.8% +72% 30 Sep 2023
Q2 2023 9.2% +4.9% +113% 30 Jun 2023
Q1 2023 8.2% +4.7% +133% 31 Mar 2023
Q4 2022 6.4% +3.7% +134% 31 Dec 2022
Q3 2022 5.2% +3.1% +148% 30 Sep 2022
Q2 2022 4.3% 30 Jun 2022
Q1 2022 3.5% 31 Mar 2022
Q4 2021 2.8% 31 Dec 2021
Q3 2021 2.1% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.